Key facts
- Respair’s last known valuation is $9.2M (Jun 2025).
- It has raised $2.5M across 1 recorded rounds; the latest was Seed Round ($2.2M) in May 2025.
- Notable investors include Innovation Works, PIC Investment Group, AlphaLab Health, Global Center for Medical Innovation, LifeX Ventures — 7 tracked in total.
- Respair has filed 1 Form D with the SEC, most recently Jun 2025 ($2.2M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Respair
Funding rounds
1 roundsAbout Respair
Developer of airway products intended to support clinicians and patients in critical care environments. The company's technology replaces the error-prone inflatable cuff used on current breathing tubes with soft, pliable baffles that act like a stopper and comprehensively seal the airway without adding pressure, enabling patients to breathe without any secondary complications.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2020
- Employees
- 6
- Website
- respairmed.com/
- Ownership
- Privately Held (backing)
Respair doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Respair shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Respair in its N-PORT filings yet. We sweep new filings monthly.